Buspirone as a Potential Treatment for Recurrent Central Apnea

NCT00746954 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

8

Enrollment

FED

Sponsor class

Stopped Patient recruitment and Funding inadequate to finish trial

Conditions

Central Apnea
Heart Failure

Interventions

DRUG: Acetazolamide
DRUG: Buspirone

Sponsor

VA Office of Research and Development

Collaborators

[object Object]